Plasma Partners: Coalition for Hemophilia B

03/23/2021

The Coalition for Hemophilia B’s (www.hemob.org) mission is to make the quality of life the focal point of treatment for people with hemophilia B and their families through education, empowerment, advocacy, and outreach. For 30 years we have driven our mission through a family-oriented approach because hemophilia affects the whole family.

Hemophilia is a disorder in which the blood does not clot properly. The two most common types, hemophilia A and hemophilia B, are caused by defective or missing proteins that are part of the clotting system, also called the coagulation cascade. In hemophilia B, the defective or missing protein is called factor IX.

Hemophilia was originally thought to be a disorder that affects primarily males, but a significant number of females are now properly being diagnosed as having hemophilia. There are several other bleeding disorders, most caused by defects in or the absence of other proteins of the clotting system. The most common of these is von Willebrand disease. Most of the others are extremely rare.

There is no cure for hemophilia B or other bleeding disorders. They are treated primarily with replacement therapies, usually clotting factor, although many new therapies are in the late stages of development. The original clotting factor products were made primarily from human plasma, although today most patients use products made through recombinant technology. However, some patients still use plasma-derived therapies.

You can find the Coalition for Hemophilia B's blog here: www.facebook.com/HemophiliaB.

News & Updates

Get the latest information regarding plasma in through our news & updates. Featuring: Scientific discoveries, plasma supply, industry related coverage, policy and legislation, and more!

Guillain-Barré Syndrome, chronic inflammatory demyelinating polyneuropathy, and plasma

05/18/2023

Read More

FDA proposes risk-based rules for plasma and blood donations

05/17/2023

On January 27, 2023, the U.S. Food and Drug Administration announced a draft proposal for eligibility rules for blood and blood product donation using “gender-inclusive, individual risk-based questions to reduce the risk of transfusion-transmitted HIV.”
Read More

Stiff person syndrome and plasma

04/25/2023

Read More

What could disqualify you from being a plasma donor?

02/23/2023

Read More

What’s the difference between blood and plasma donation?

01/05/2023

Many believe that blood and plasma donation are the same, but there are many differences between these two lifesaving processes.
Read More

What is plasmapheresis?

10/06/2022

Read More
Powered By:
Mojo Creative Digital